WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Nasdaq-traded Chinese herb company hits near $30 billion market value after speculative surge

The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 40,000% year to date.

Raccontata dacnbc.comupi.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
cnbc.comStai leggendo1 anni fa

Nasdaq-traded Chinese herb company hits near $30 billion market value after speculative surge

The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 40,000% year to date.

originale
upi.com1 anni fa

Investors flock to Chinese herbal medicine stock with no revenues - UPI.com

Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split despite the firm reporting no revenues.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 17 giugno 2025·cnbc.com

    Nasdaq-traded Chinese herb company hits near $30 billion market value after speculative surge

    The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 40,000% year to date.

  2. mercoledì 18 giugno 2025·upi.com

    Investors flock to Chinese herbal medicine stock with no revenues - UPI.com

    Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split despite the firm reporting no revenues.